Today's Low
₹ 1,924.90
Today's High
₹ 1,949.95
52 Weeks Low
₹ 766.85
52 Weeks High
₹ 1,726.25
Lower
₹ 1,532.95
Upper
₹ 2,299.35
Bhagiradha Chemicals & Industries Limited manufactures and sells agrochemicals in India. The company offers insecticides, such as chlorpyrifos, chlorpyrifos-methyl, diafenthiuron, fipronil, buprofezin, thiamethoxam, and imidacloprid; fungicides that include azoxystrobin; herbicides, such as imazethapyr, cloquintocet-mexyl, and clodinafop-propargyl; and specialty intermediates, including hydroxyphenoxy propionic acid, dichloroaniline, and O-methylisourea hydrochloride products, as well as triclopyr; and intermediates of sulfosulfuron, penoxsulam, diclosulam, pyroxsulam, pinoxaden, etc. It also provides contract manufacturing services. The company exports its products to the United States, Brazil, Columbia, Argentina, Mexico, Costa Rica, Germany, the United Kingdom, France, Portugal, Italy, Israel, Turkey, Iran, Indonesia, Taiwan, Malaysia, New Zealand, and Australia. Bhagiradha Chemicals & Industries Limited was incorporated in 1993 and is headquartered in Hyderabad, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|
Total Current Assets | 228.3 | 173.9 | 114.1 | 78.6 |
Total Non-Current Assets | 218.7 | 168.1 | 159.1 | 145.1 |
Total Assets | 446.9 | 342.0 | 273.2 | 223.6 |
Total Current Liabilities | 100.8 | 132.7 | 95.1 | 83.1 |
Total Non-Current Liabilities | 32.9 | 19.5 | 22.4 | 8.3 |
Shareholder's Funds | 313.3 | 189.9 | 155.7 | 132.2 |
Total Liabilities | 446.9 | 342.0 | 273.2 | 223.6 |
The Industry Quick Ratio stands at 1.58, vs the Quick Ratio of 0.27, which results in a Negative aspect.
The Industry Price to BV stands at 4.75, vs the Price to BV of 6.11, which results in a Positive aspect.
The Industry Debt to Equity Ratio stands at 0.39, vs the Debt to Equity Ratio of 0.32, which results in a Positive aspect.
The Industry Current Ratio stands at 2.23, vs the Current Ratio of 0.95, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|
Total Income | 502.1 | 435.7 | 317.9 | 245.7 |
Total Expenditure | 424.8 | 367.4 | 271.0 | 228.8 |
Operating Profit(Excl OI) | 78.6 | 69.1 | 47.5 | 18.6 |
Add: Other Income | 1.3 | 0.9 | 0.6 | 1.7 |
Operating Profit | 78.6 | 69.1 | 47.5 | 18.6 |
Less: Interest | 5.0 | 9.1 | 8.3 | 5.5 |
PBDT | 73.6 | 60.0 | 39.3 | 13.1 |
Less: Depreciation Amortization | 9.8 | 8.7 | 8.2 | 6.7 |
PBT & Exceptional Items | 63.8 | 51.3 | 31.1 | 6.5 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 1.1 | 2.5 |
Profit Before Tax | 63.8 | 51.3 | 32.1 | 8.9 |
Less: Taxation | 18.6 | 15.6 | 8.8 | 2.4 |
Profit After Tax | 45.2 | 35.8 | 23.3 | 6.5 |
Earnings Per Share | 0.4 | 0.4 | 0.3 | 0.0 |
The Industry PAT Growth stands at 31.52, vs the PAT Growth of 0.00, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.78, vs the Dividend Yield of 0.21, which results in a Negative aspect.
The Industry PE Ratio stands at 30.15, vs the PE Ratio of 96.19, which results in a Positive aspect.
The Industry PAT Margin stands at 11.47, vs the PAT Margin of 2.65, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|
Profit Before Tax | 63.8 | 51.3 | 32.1 | 8.9 |
Tax Paid | -11.9 | -8.1 | -5.6 | -3.2 |
Adjustment | 12.3 | 14.0 | 13.2 | 10.4 |
Changes In Working Capital | 63.8 | 51.3 | 32.1 | 8.9 |
Cash Flow after changes in Working Capital | 25.8 | 14.7 | 9.2 | 51.4 |
Cash Flow from Operating Activities | 13.9 | 6.6 | 3.6 | 48.2 |
Cash Flow from Investing Activities | -59.6 | -17.1 | -20.8 | -38.6 |
Cash Flow from Financing Activities | 46.5 | 12.4 | 14.8 | -9.1 |
Net Cash Inflow / Outflow | 0.7 | 1.9 | -2.4 | 0.4 |
Opening Cash & Cash Equivalents | 2.2 | 0.3 | 2.7 | 2.3 |
Closing Cash & Cash Equivalent | 2.9 | 2.2 | 0.3 | 2.7 |
The Industry PCF RATIO stands at 30.01, vs the PCF RATIO of 3.80, which results in a Negative aspect.
The Industry PFCF Ratio stands at 14.68, vs the PFCF Ratio of 28.64, which results in a Positive aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 743.7 | 1,220.1 | 1,000.1 | 1,225.7 | 1,260.0 | 1,318.1 | 1,217.2 | 1,377.2 | 1,001.1 | 993.8 | 984.5 | 974.7 | 692.5 | 897.9 |
Total Income | 751.3 | 1,221.5 | 1,003.3 | 1,227.8 | 1,265.0 | 1,321.8 | 1,218.9 | 1,380.6 | 1,003.5 | 995.3 | 985.8 | 975.7 | 694.1 | 900.7 |
Total Expenditure | 661.0 | 1,085.6 | 929.1 | 1,043.5 | 1,066.8 | 1,116.2 | 1,021.3 | 1,172.7 | 837.5 | 829.6 | 834.1 | 827.1 | 573.0 | 763.1 |
PBIDT (Excl OI) | 82.8 | 134.5 | 71.0 | 182.2 | 193.2 | 201.9 | 195.9 | 204.5 | 163.6 | 164.2 | 150.4 | 147.5 | 119.5 | 134.9 |
Other Income | 7.6 | 1.3 | 3.2 | 2.2 | 5.0 | 3.7 | 1.7 | 3.3 | 2.4 | 1.5 | 1.3 | 1.0 | 1.6 | 2.8 |
Operating Profit | 90.4 | 135.9 | 74.2 | 184.4 | 198.2 | 205.6 | 197.7 | 207.9 | 166.0 | 165.7 | 151.7 | 148.5 | 121.1 | 137.6 |
Interest | 15.6 | 22.7 | 17.2 | 15.5 | 8.5 | 8.2 | 17.7 | 20.6 | 19.6 | 29.0 | 21.8 | 24.4 | 19.2 | 22.4 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.5 | 0.0 |
PBDT | 74.7 | 113.2 | 57.0 | 168.9 | 189.7 | 197.4 | 180.0 | 187.3 | 146.5 | 136.7 | 129.9 | 124.2 | 112.5 | 115.2 |
Depreciation | 26.8 | 28.1 | 26.3 | 25.8 | 24.8 | 24.3 | 23.2 | 22.4 | 22.1 | 21.7 | 21.2 | 21.4 | 20.6 | 20.1 |
Profit Before Tax | 47.9 | 85.1 | 30.7 | 143.0 | 164.9 | 173.1 | 156.8 | 165.0 | 124.4 | 115.1 | 108.7 | 102.7 | 91.9 | 95.1 |
Tax | 14.7 | 27.9 | 11.0 | 49.1 | 48.4 | 51.0 | 37.7 | 56.2 | 35.2 | 31.6 | 32.7 | 29.6 | 21.0 | 31.8 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 33.2 | 57.2 | 19.7 | 93.9 | 116.5 | 122.1 | 119.0 | 108.8 | 89.2 | 83.5 | 76.0 | 73.2 | 70.9 | 63.3 |
Net Profit | 33.2 | 57.2 | 19.7 | 93.9 | 116.5 | 122.1 | 119.0 | 108.8 | 89.2 | 83.5 | 76.0 | 73.2 | 70.9 | 63.3 |
ADDITIONAL INFOS: | ||||||||||||||
Equity Capital | 104.1 | 104.1 | 104.1 | 104.1 | 104.1 | 104.1 | 104.1 | 83.3 | 83.1 | 83.3 | 83.1 | 83.3 | 83.1 | 83.3 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 3.2 | 5.5 | 1.9 | 9.0 | 11.2 | 11.7 | 12.5 | 13.0 | 10.7 | 10.1 | 9.1 | 8.8 | 8.5 | 7.6 |
Operating Profit Margin | 12.1 | 11.1 | 7.4 | 15.0 | 15.7 | 15.6 | 16.2 | 15.1 | 16.6 | 16.7 | 15.4 | 15.2 | 17.5 | 15.3 |
Net Profit Margin | 4.5 | 4.7 | 2.0 | 7.7 | 9.2 | 9.3 | 9.8 | 7.9 | 8.9 | 8.4 | 7.7 | 7.5 | 10.2 | 7.0 |
The Industry Mcap Growth stands at 343.80, vs the Mcap Growth of 0.00, which results in a Negative aspect.
The Industry Net Sales Growth stands at 22.13, vs the Net Sales Growth of 0.00, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 1,998.80 | 2,036.68 | 1,947.18 |
R3 | 1,982.52 | 1,981.00 | 1,937.39 |
R2 | 1,966.23 | 1,965.48 | 1,934.13 |
R1 | 1,946.92 | 1,945.40 | 1,930.86 |
Pivot | 1,930.63 | 1,929.88 | 1,930.63 |
S1 | 1,911.32 | 1,909.80 | 1,924.34 |
S2 | 1,895.03 | 1,894.28 | 1,921.07 |
S3 | 1,875.72 | 1,874.20 | 1,917.81 |
S4 | 1,856.40 | 1,823.08 | 1,908.02 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
73.11
Neutral
RSI
63.02
Neutral
ROC
16.69
Bullish
UltimateOscillator
50.08
Neutral
Williams Indicator
-18.44
Bearish
CCI Indicator
138.32
Bearish
MACD
-1,627.34
Bearish
Stochastic Indicator
80.20
Neutral
ATR
96.29
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
17-11-2023 | 0.00 | 0 | Interim |
27-07-2023 | 3.00 | 30 | Final |
16-11-2022 | 1.00 | 10 | Interim |
04-08-2022 | 2.00 | 20 | Final |
11-11-2021 | 1.00 | 10 | Interim |
Date Of Conduct | Board Meeting Details |
---|---|
05-03-2024 | Stock Split |
27-01-2024 | Quarterly Results |
17-11-2023 | Inter alia, to consider Allotment of Convertible Warrants |
04-11-2023 | Interim Dividend(Cancelled) |
11-10-2023 | Preferential Issue of shares & Issue Of Warrants & Rights Issue |
04-08-2023 | Quarterly Results |
13-05-2023 | Final Dividend & A.G.M. & Audited Results |
28-01-2023 | Quarterly Results |
04-11-2022 | Interim Dividend & Quarterly Results |
08-08-2022 | Quarterly Results |
26-05-2022 | Audited Results & Final Dividend & A.G.M. |
05-04-2022 | Right Issue of Equity Shares |
29-01-2022 | Quarterly Results |
04-01-2022 | Increase in Authorised Capital Inter alia to consider a proposal for increase in the Authorised Capital and consequent amendment to Memorandum of Association of the Company, to consider issue of equity shares of the Company to its employees in the proposed rights issue by the Company approved by the Board of Directors at its meeting held on December 14, 2021 and such other items as per the agenda. |
14-12-2021 | Right Issue of Equity Shares Inter alia, consider a proposal to issue equity shares to existing shareholders of the Company on rights basis as may be permitted under applicable law, subject to such consents and approvals including regulatory/statutory approvals as may be required. |
30-10-2021 | BHAGIRADHA CHEMICALS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2021 ,inter alia, to consider and approve In continuation to our letter dated October 22, 2021, we wish to inform that the Board of Directors of the Company at their meeting scheduled to be held on Saturday, October 30, 2021, may consider and declare 1st Interim Dividend for the financial year 2021-22 |
12-08-2021 | BHAGIRADHA CHEMICALS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2021 ,inter alia, to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) for the Quarter ended 30th June, 2021, and the Limited Review Report of the Statutory Auditors of the Company on the Un-Audited Financial Results (Standalone & Consolidated) for the Quarter ended 30th June, 2021. |
04-05-2021 | A.G.M. & Audited Results |